JLK, Inc. (KOSDAQ:322510)

South Korea · Delayed Price · Currency is KRW

4,975.00

+115.00 (2.37%)

Aug 3, 2026, 3:30 PM KST

-14.81% (1Y)

Market Cap	123.37B -16.1%
Revenue (ttm)	3.27B +83.9%
Net Income	-14.21B
EPS	-561.54
Shares Out	25.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	97,549
Open	4,850.00
Previous Close	4,860.00
Day's Range	4,695.00 - 5,160.00
52-Week Range	3,765.00 - 9,210.00
Beta	1.27
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About JLK, Inc.

JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, ... [Read more]

Industry Conglomerates

Sector Industrials

Founded 2014

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 322510

Full Company Profile

Financial Performance

In 2025, JLK, Inc.'s revenue was 3.34 billion, an increase of 133.94% compared to the previous year's 1.43 billion. Losses were -13.61 billion, 1.13% more than in 2024.

Financial Statements